618319
Last Update Posted: 2015-10-02
Recruiting has ended
All Genders accepted | 18 Years + |
20 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)
This study will examine the effect of BIIB021 on GIST growth and metabolism.
Eligibility
Relevant conditions:
GIST
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov